Literature DB >> 28611166

Cytomegalovirus duodenitis in immunocompetent patients: what else should we look for?

Dalila Costa1,2,3, Dália Fernandes1, Antónia Furtado4, Andre Santa Cruz2,3,5.   

Abstract

Cytomegalovirus (CMV) infection is a well-recognised complication of immunodeficiency, although the burden of CMV disease in immunocompetent adults is still unknown. We present the case of a 54-year-old male patient admitted due to severe diarrhoea, epigastric pain and fever. Initial diagnostic workup revealed pericardial and pleural effusion, enlarged abdominal lymph nodes and mild elevation of liver enzymes. CMV serology was IgM positive, and upper endoscopy revealed proximal enteritis. Histology and immunohistochemistry of duodenal samples confirmed CMV disease. An extensive investigation of possible immunodeficiency was conducted with positron emission tomography (PET) scan revealing an abnormal hypermetabolic pulmonary nodule. The patient underwent a right superior lobectomy which, on analysis, confirmed an atypical bronchopulmonary carcinoid tumour. We report this case to reinforce the importance of considering CMV infection as a differential diagnosis in apparent immunocompetent patients and to emphasise the importance of looking for any condition that may cause any degree of immune dysfunction. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  endoscopy; infection (gastroenterology); stomach and duodenum

Mesh:

Substances:

Year:  2017        PMID: 28611166      PMCID: PMC5534848          DOI: 10.1136/bcr-2017-219679

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Endoscopic subtlety: rest assured only when biopsied.

Authors:  Ramakrishnan Arulraj; Paul Dunn; Ian Gee
Journal:  Gastroenterology       Date:  2012-03-27       Impact factor: 22.682

2.  Cytomegalovirus reactivation in "immunocompetent" patients: a call for scientific prophylaxis.

Authors:  Charles H Cook
Journal:  J Infect Dis       Date:  2007-10-01       Impact factor: 5.226

Review 3.  Hepatitis C virus infection: a "liaison a trois" amongst the virus, the host, and chronic low-level inflammation for human survival.

Authors:  Vincenzo Barnaba
Journal:  J Hepatol       Date:  2010-06-25       Impact factor: 25.083

4.  Cytomegalovirus ileitis associated with goblet cell carcinoid tumour of the appendix.

Authors:  Siew C Ng; Mahdad Noursadeghi; Axel von Herbay; Carolynne Vaizey; Maxton C Pitcher; Katie L Flanagan
Journal:  J Infect       Date:  2006-10-16       Impact factor: 6.072

5.  Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases.

Authors:  Luca Reggiani Bonetti; Luisa Losi; Carmela Di Gregorio; Angela Bertani; Antonio Merighi; Stefania Bettelli; Monica Scuri; Antonio Maiorana
Journal:  Scand J Gastroenterol       Date:  2011-06-22       Impact factor: 2.423

Review 6.  Cytomegalovirus infection in non-immunosuppressed critically ill patients.

Authors:  Manisha Jain; Shalini Duggal; Tulsi Das Chugh
Journal:  J Infect Dev Ctries       Date:  2011-08-12       Impact factor: 0.968

Review 7.  Cytomegalovirus pseudotumor of the duodenum in a patient with AIDS: an unrecognized and potentially treatable clinical entity.

Authors:  Theodoros Kelesidis; Shirly Tozzi; Roger Mitty; Michael Worthington; Jorge Fleisher
Journal:  Int J Infect Dis       Date:  2009-08-19       Impact factor: 3.623

Review 8.  Cytomegalovirus cell tropism.

Authors:  C Sinzger; M Digel; G Jahn
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 9.  A model for reactivation of CMV from latency.

Authors:  Mary Hummel; Michael M Abecassis
Journal:  J Clin Virol       Date:  2002-08       Impact factor: 3.168

Review 10.  Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.

Authors:  Petros I Rafailidis; Eleni G Mourtzoukou; Ioannis C Varbobitis; Matthew E Falagas
Journal:  Virol J       Date:  2008-03-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.